未登录

M

Marcelo R. Choi

universidad de buenos aires

H指数:13

被引数:623

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effects of Losartan on Renal Dopaminergic and Renin–Angiotensin System Alterations Induced by a High-Fat Diet in Sprague-Dawley Rats

洛沙坦对高脂饮食诱导的斯普瑞格-道利大鼠肾多巴胺能和肾素-血管紧张素系统改变的影响

International Journal of Molecular Sciences

IF4.9

2026-10-140

OA

EFFECTS OF HIGH-FAT AND HIGH-SALT DIETS ON MESENTERIC ADIPOSE TISSUE: ROLE OF THE NATRIURETIC PEPTIDE SYSTEM

高脂和高铁饮食对肠系膜脂肪组织的影响：心钠肽系统的角色

JOURNAL OF HYPERTENSION

IF4.1

2025-05-010

PRE

IMPACT OF THE INHIBITION OF RENAL DOPAMINERGIC SYSTEM ON BLOOD PRESSURE AND INFLAMMATORY RESPONSE IN THE KIDNEY

肾多巴胺能系统抑制对血压和肾脏炎症反应的影响

JOURNAL OF HYPERTENSION

IF4.1

2025-05-010

PRE

Microbiota, mitochondria, and epigenetics in health and disease: converging pathways to solve the puzzle

微生物组、线粒体和表观遗传学在健康与疾病中的作用：解决这一难题的汇聚途径

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY

IF2.9

2025-03-200

PRE

Efavirenz Repurposing Challenges: A Novel Nanomicelle-Based Antiviral Therapy Against Mosquito-Borne Flaviviruses

IF5.5

2025-02-120

OAAI

Physiopathological mechanisms involved in the development of hypertension associated with gut dysbiosis and the effect of nutritional/ pharmacological interventions

BIOCHEMICAL PHARMACOLOGY

IF5.6

2022-10-016

PRE

Protective Renal Effects of Atrial Natriuretic Peptide: Where Are We Now?

FRONTIERS IN PHYSIOLOGY

IF3.4

2021-05-2820

OAAI

Cardiac Natriuretic Peptide Profiles in Chronic Hypertension by Single or Sequentially Combined Renovascular and DOCA-Salt Treatments

FRONTIERS IN PHYSIOLOGY

IF3.4

2021-05-259

OAAI

Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis

Pflugers Archiv-European Journal of Physiology

IF2.9

2020-02-170

PREAI

METFORMIN AND LOSARTAN EFFECTS ON VASCULAR PROSTANOIDS RELEASE IN TWO MODELS OF DIETARY ALTERATION IN THE RAT

JOURNAL OF HYPERTENSION

IF4.1

2019-07-010

OAAI

EFFECTS OF LOSARTAN ON METABOLIC PROFILE, VISCERAL ADIPOSITY AND VASCULAR PROSTANOIDS IN HIGH-FAT DIET FED RATS

JOURNAL OF HYPERTENSION

IF4.1

2018-10-010

PREAI

Losartan prevents the imbalance between renal dopaminergic and renin angiotensin systems induced by fructose overload. L-Dopa/dopamine index as new potential biomarker of renal dysfunction

METABOLISM-CLINICAL AND EXPERIMENTAL

IF11.9

2018-08-0116

OAAI

LOSARTAN NORMALIZES BLOOD PRESSURE AND PREVENTS RENAL DAMAGE AND INFLAMMATION INDUCED BY FRUCTOSE OVERLOAD. L-DOPA/DOPAMINE INDEX AS A NEW POTENTIAL BIOMARKER OF RENAL DAMAGE

JOURNAL OF HYPERTENSION

IF4.1

2018-06-010

PREAI

Effects of chronic fructose overload on renal dopaminergic system: alteration of urinary L-dopa/dopamine index correlates to hypertension and precedes kidney structural damage

JOURNAL OF NUTRITIONAL BIOCHEMISTRY

IF4.9

2018-01-0111

OAAI

EFFECTS OF LOSARTAN ON PROSTANOIDS RELEASE IN TWO MODELS OF METABOLIC ALTERATION IN THE RAT

JOURNAL OF HYPERTENSION

IF4.1

2017-09-010

PREAI

RENAL DOPAMINERGIC SYSTEM DYSFUNCTION ASSOCIATED TO HIGH BLOOD PRESSURE AND INFLAMMATION IN FRUCTOSE OVERLOAD INDUCED METABOLIC SYNDROME

JOURNAL OF HYPERTENSION

IF4.1

2017-09-010

PREAI

A phase 2 study of poziotinib in patients with HER2-positive metastatic breast cancer (MBC) who have received prior HER2 regimens for MBC

CANCER RESEARCH

IF16.6

2017-02-150

PRE

METFORMIN REDUCES HIGH-FAT DIET EFFECTS ON BLOOD PRESSURE, METABOLIC PARAMETERS AND VASCULAR PROSTANOIDS IN RATS

JOURNAL OF HYPERTENSION

IF4.1

2016-09-010

PREAI

EFFECT OF METFORMIN ON BLOOD PRESSURE IN HIGH-FAT DIET-FED RATS

JOURNAL OF HYPERTENSION

IF4.1

2016-09-010

PREAI

Randomized phase 2, open-label, dose-ranging study of a novel, long-acting G-CSF (SPI-2012) or pegfilgrastim for the management of neutropenia in patients with breast cancer (BC) treated with (Neo) adjuvant chemotherapy with docetaxel plus cyclophosphamide (TC)

CANCER RESEARCH

IF16.6

2016-02-150

PRE